Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.37 |
| ▸ | TNF | P01375 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29512050 | 1.00 | CYP1A2 (0.44) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL13682513 | 0.91 | CYP1A2 (0.41) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL13682531 | 0.91 | CYP1A2 (0.41) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL29357128 | 0.86 | CYP1A2 (0.52) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL261910 | 0.86 | CYP1A2 (0.52) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL12345142 | 0.86 | CYP11B1 (0.46) | CYP3A4CYP11B1CYP11B2CYP17A1TNF | |
| SCHEMBL17680306 | 0.85 | CYP2A6 (0.43) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL17116565 | 0.85 | CYP11B1 (0.40) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL29756488 | 0.84 | CYP1A2 (0.50) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL16177320 | 0.84 | CYP1A2 (0.50) | CYP1A2ERBB2FYNMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240004204-A1 | SYSTEMS AND APPARATUSES FOR OPTICAL MODULATION VIA MANIPULATION OF CHARGE CARRIERS | META PLATFORMS TECHNOLOGIES, LLC | 2024-01-04 | — | — | US | claimed |
| EP-4300174-A1 | SYSTEMS AND APPARATUSES FOR OPTICAL MODULATION VIA MANIPULATION OF CHARGE CARRIERS | Meta Platforms Technologies, LLC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-3151301-B1 | ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO LTD (KR) | 2023-08-30 | — | — | EP | claimed |
| CN-114940684-A | White light luminescent copper halide complex and preparation method and application thereof | 浙江大学温州研究院 | 2022-08-26 | — | — | CN | claimed |
| EP-3230295-B1 | AMINO PHOSPHAZENE BASES AS N-DOPANTS IN ORGANIC ELECTRONICS | SIEMENS AG (DE) | 2019-07-31 | — | — | EP | claimed |
| US-10361376-B2 | Proazaphosphatranes as n-dopants in organic electronics | SIEMENS AKTIENGESELLSCHAFT (DE) | 2019-07-23 | — | — | US | claimed |
| EP-3233873-B1 | PROAZAPHOSPHATRANES AS N-DOPANTS IN ORGANIC ELECTRONICS | SIEMENS AG (DE) | 2019-06-26 | — | — | EP | claimed |
| US-10230050-B2 | Amino phosphazene bases as n-dopants in organic electronics | SIEMENS AKTIENGESELLSCHAFT (DE) | 2019-03-12 | — | — | US | claimed |
| US-20180019396-A1 | Amino Phosphazene Bases As N-Dopants In Organic Electronics | SIEMENS AKTIENGESELLSCHAFT (DE) | 2018-01-18 | — | — | US | claimed |
| US-20180006240-A1 | Proazaphosphatranes As N-Dopants In Organic Electronics | SIEMENS AKTIENGESELLSCHAFT (DE) | 2018-01-04 | — | — | US | claimed |
| US-20150097167-A1 | ORGANIC LIGHT EMITTING DEVICE AND ORGANIC LIGHT EMITTING DISPLAY HAVING THE SAME | LG DISPLAY CO., LTD. (KR) | 2015-04-09 | — | — | US | claimed |
| US-20260120949-A1 | CHARGE OR ELECTRICITY GENERATING DEVICES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-12213327-B2 | Charge or electricity generating devices and methods of making and use thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2025-01-28 | — | — | US | disclosed |
| EP-3327815-B1 | LIGHT-EMITTING DEVICE | IMEC VZW (BE) | 2024-11-06 | — | — | EP | disclosed |
| US-11935803-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-19 | — | — | US | disclosed |
| US-20150097167-A1 | ORGANIC LIGHT EMITTING DEVICE AND ORGANIC LIGHT EMITTING DISPLAY HAVING THE SAME | LG DISPLAY CO., LTD. (KR) | 2015-04-09 | — | — | US | disclosed |
| US-20150077966-A1 | LIGHT-SCATTERING BODY, LIGHT-SCATTERING BODY FILM, LIGHT-SCATTERING BODY SUBSTRATE, LIGHT-SCATTERING BODY DEVICE, LIGHT-EMITTING DEVICE, DISPLAY DEVICE, AND ILLUMINATION DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2015-03-19 | — | — | US | disclosed |
| US-20150042933-A1 | FLUORESCENT SUBSTRATE AND DISPLAY DEVICE PROVIDED WITH SAME | Sharp Kabushiki Kaidsha (JP) | 2015-02-12 | — | — | US | disclosed |
| US-20150003040-A1 | LIGHT-EMITTING DEVICE, DISPLAY APPARATUS, ILLUMINATION APPARATUS, AND ELECTRICITY-GENERATING APPARATUS | SHARP KABUSHIKI KAISHA (JP) | 2015-01-01 | — | — | US | disclosed |
| CN-103733244-A | Light emitting device, display device, lighting device, and power generation device | SHARP KK | 2014-04-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10361376-B2 | Proazaphosphatranes as n-dopants in organic electronics | PNP, NUDT1, SLC29A1 | CYP1A2 1280/4885ERBB2 3575/4885FYN 1742/4885 |
| US-10230050-B2 | Amino phosphazene bases as n-dopants in organic electronics | PHOSPHO1, SLC29A1, NME2 | CYP1A2 3140/4885ERBB2 1262/4885FYN 2196/4885 |
| US-20260120949-A1 | CHARGE OR ELECTRICITY GENERATING DEVICES AND METHODS OF MAKING AND USE THEREOF | SLC9A2, SLC9A3, SLC9A1 | CYP1A2 1089/4885ERBB2 3176/4885FYN 3185/4885 |
| US-20180006240-A1 | Proazaphosphatranes As N-Dopants In Organic Electronics | PNP, NUDT1, SLC29A1 | CYP1A2 1280/4885ERBB2 3575/4885FYN 1742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.